After attending the CC CDQ Workshop in Munich in June 2017 as a guest, Philip Morris International (PMI) is now an official member of the Competence Center Corporate Data Quality (CC CDQ). We would like to extend a very warm welcome to Philip Morris International!
Earlier this year, PMI established an Enterprise Analytics and Data (EAD) business function, whose objective is to transform PMI into a more data and analytics driven organization by building up capabilities that enhance company agility in transforming data into real-time analytics used by all functions to generate actionable insights and real, measurable, business value.
There are two key pillars of EAD:
• Analytics: This is about developing the skills and culture to surface game-changing insights for the business, delivered by an internal PMI data science team – specialists in mathematics and statistical modelling – in close collaboration with business users, who understand the business challenges addressed.
• Data: Having well-organized, good-quality data is key to accelerating the analytics process. PMI enterprise data teams work with functional counterparts to agree on a common set of definitions for key PMI data (such as consumer data, product data, or vendor data) and set up governance processes and identify data owners in key functional areas to improve the organization and management of the data. This will be achieved by standardizing and optimizing the company’s master data processes and services across all functions (including the implementation of modern tools for data capture, automatic quality controls and validations, and imbedded workflows) and ensuring that legal and data protection related implications are considered and reflected in the way data is collected, managed and used.
PMI is a leading international tobacco company, with six of the world's top 15 international brands and products sold in more than 180 markets. In addition to the manufacture and sale of cigarettes, including Marlboro, the number one global cigarette brand, and other tobacco products, PMI is engaged in the development and commercialization of Reduced-Risk Products ("RRPs"). RRPs is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. Through multidisciplinary capabilities in product development, state-of-the-art facilities, and industry-leading scientific substantiation, PMI aims to provide an RRP portfolio that meets a broad spectrum of adult smoker preferences and rigorous regulatory requirements. For more information, see www.pmi.com and www.pmiscience.com.